| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 2398-2403, Copyright © 1994 by Endocrine Society
ARTICLES |
P Plaisancie, C Bernard, JA Chayvialle and JC Cuber
INSERM U-45, Hopital E. Herriot, Lyon, France.
Glucagon-like peptide-1 (GLP-1) is promptly released from endocrine cells of the distal part of the gut after oral ingestion of a meal. To test the possibility that hormones produced by the proximal small intestine or transmitters of the enteric nervous system may be involved in the early phase of meal-induced GLP-1 secretion, various intestinal regulatory peptides and neurotransmitters of the gut were administered intraarterially in the isolated vascularly perfused rat colon preparation. The release of GLP-1 in the portal effluent was measured by a specific RIA. Intraarterial infusion of glucose-dependent insulinotropic peptide (GIP) over the concentration range 0.25-1 nM evoked a dose-dependent release of GLP-1, with a maximal response of 350% of the basal value. Tetrodotoxin did not modify the GIP-induced release of GLP-1. Secretin or cholecystokinin did not stimulate the secretion of GLP-1. Bombesin (10(-9)-10(-7) M) provoked a dose- dependent release of GLP-1, consisting of an early peak, followed by a sustained response. Calcitonin gene-related peptide (5 x 10(-8) M) induced a dramatic rise of GLP-1 immunoreactivity in the portal effluent (peak at 800% of the basal value 10 min after the start of infusion). Similarly, the beta-adrenergic agonist isoproterenol at concentrations of 10(-7) and 10(-6) M provoked a pronounced release of GLP-1 (peak at 500% of the basal value with 10(-6) M isoproterenol). Finally, the muscarinic cholinergic agonist bethanechol at a concentration of 10(-4) M evoked a gradual increase in GLP-1 immunoreactivity, which reached a maximal value (900% over basal) at the end of the 30-min infusion period. The lowest concentration of bethanechol used in the present study (10(-5) M) did not increase portal GLP-1 immunoreactivity over the basal value. Tetrodotoxin did not modify the bethanechol-, isoproterenol-, calcitonin gene-related peptide-, or bombesin-induced GLP-1 release. In conclusion, the present study conducted with the isolated vascularly perfused rat colon shows that there are interactions between the two most potent incretins, GIP and GLP-1, probably through an enteroendocrine pathway. Additionally, several transmitters of the gut are potent stimulants of GLP-1 release and, therefore, represent potential tools in the treatment of the noninsulin-dependent diabetes mellitus.
This article has been cited by other articles:
![]() |
Z.-L. Chu, C. Carroll, J. Alfonso, V. Gutierrez, H. He, A. Lucman, M. Pedraza, H. Mondala, H. Gao, D. Bagnol, et al. A Role for Intestinal Endocrine Cell-Expressed G Protein-Coupled Receptor 119 in Glycemic Control by Enhancing Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Peptide Release Endocrinology, May 1, 2008; 149(5): 2038 - 2047. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Holst The Physiology of Glucagon-like Peptide 1 Physiol Rev, October 1, 2007; 87(4): 1409 - 1439. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Lim and P. L. Brubaker Glucagon-Like Peptide 1 Secretion by the L-Cell: The View From Within Diabetes, December 1, 2006; 55(Supplement_2): S70 - S77. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Qin, H. Shen, M. Liu, Q. Yang, S. Zheng, M. Sabo, D. A. D'Alessio, and P. Tso GLP-1 reduces intestinal lymph flow, triglyceride absorption, and apolipoprotein production in rats Am J Physiol Gastrointest Liver Physiol, May 1, 2005; 288(5): G943 - G949. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hansen, S. Lampert, H. Mineo, and J. J. Holst Neural regulation of glucagon-like peptide-1 secretion in pigs Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E939 - E947. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Anini, T. Hansotia, and P. L. Brubaker Muscarinic Receptors Control Postprandial Release of Glucagon-Like Peptide-1: In Vivo and in Vitro Studies in Rats Endocrinology, June 1, 2002; 143(6): 2420 - 2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cuche, J. C. Cuber, and C. H. Malbert Ileal short-chain fatty acids inhibit gastric motility by a humoral pathway Am J Physiol Gastrointest Liver Physiol, November 1, 2000; 279(5): G925 - G930. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Moro, F. Levenez, E. Nemoz-Gaillard, S. Pellissier, P. Plaisancie, and J. C. Cuber Release of Guanylin Immunoreactivity from the Isolated Vascularly Perfused Rat Colon Endocrinology, July 1, 2000; 141(7): 2594 - 2599. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hansen, B. Hartmann, T. Bisgaard, H. Mineo, P. N. Jorgensen, and J. J. Holst Somatostatin restrains the secretion of glucagon-like peptide-1 and -2 from isolated perfused porcine ileum Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E1010 - E1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Barcelo, J Claustre, F Moro, J-A Chayvialle, J-C Cuber, and P Plaisancie Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon Gut, February 1, 2000; 46(2): 218 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Kieffer and J. Francis Habener The Glucagon-Like Peptides Endocr. Rev., December 1, 1999; 20(6): 876 - 913. [Abstract] [Full Text] |
||||
![]() |
P. Plaisancie, A. Barcelo, F. Moro, J. Claustre, J.-A. Chayvialle, and J.-C. Cuber Effects of neurotransmitters, gut hormones, and inflammatory mediators on mucus discharge in rat colon Am J Physiol Gastrointest Liver Physiol, November 1, 1998; 275(5): G1073 - G1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Dumoulin, F. Moro, A. Barcelo, T. Dakka, and J.-C. Cuber Peptide YY, Glucagon-Like Peptide-1, and Neurotensin Responses to Luminal Factors in the Isolated Vascularly Perfused Rat Ileum Endocrinology, September 1, 1998; 139(9): 3780 - 3786. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Damholt, A. M. J. Buchan, and H. Kofod Glucagon-Like-Peptide-1 Secretion from Canine L-Cells Is Increased by Glucose-Dependent-Insulinotropic Peptide but Unaffected by Glucose Endocrinology, April 1, 1998; 139(4): 2085 - 2091. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |